Shopping Cart
- Remove All
- Your shopping cart is currently empty
MT-802 is an effective BTK degrader based on PROTAC technology (DC50: 1 nM). MT-802 has the potential to treat C481S mutant chronic lymphocytic leukemia (CLL).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $88 | In Stock | |
5 mg | $197 | In Stock | |
10 mg | $298 | In Stock | |
25 mg | $567 | In Stock | |
50 mg | $768 | In Stock | |
100 mg | $987 | In Stock | |
200 mg | $1,390 | In Stock | |
1 mL x 10 mM (in DMSO) | $257 | In Stock |
Description | MT-802 is an effective BTK degrader based on PROTAC technology (DC50: 1 nM). MT-802 has the potential to treat C481S mutant chronic lymphocytic leukemia (CLL). |
Targets&IC50 | BTK:1 nM(DC50) |
In vitro | MT-802 degrades BTK (DC50: 9.1 nM). The maximal degradation was observed by 250 nM. |
Molecular Weight | 787.82 |
Formula | C41H41N9O8 |
Cas No. | 2231744-29-7 |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (126.93 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.